Für Sie gelesen: Tocilizumab (TCZ) Monotherapy is Superior to Adalimumab (ADA) Monotherapy in Reducing Disease Activity in Patients with Rheumatoid Arthritis (RA): 24-Week Data from the Phase 4 ADACTA Trial
[摘要]
[发布日期] [发布机构]
[效力级别] [学科分类] 生物技术
[关键词] [时效性]
